Stay updated on Long-Term BMN 190 in CLN2 Disease Clinical Trial
Sign up to get notified when there's something new on the Long-Term BMN 190 in CLN2 Disease Clinical Trial page.

Latest updates to the Long-Term BMN 190 in CLN2 Disease Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed two specific disease resources and older version tag v3.1.0.SummaryDifference4%
- Check24 days agoChange DetectedUpdate includes standardizing the term to 'Late-infantile neuronal ceroid lipofuscinosis' and updating the revision from v3.0.2 to v3.1.0.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing the previous v3.0.1. The Back to Top link was removed, and there are no other notable changes to core content like pricing or timings.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check52 days agoChange DetectedThe webpage has been updated to include new drug information for cerliponase alfa and additional resources related to neuronal ceroid lipofuscinosis, while removing outdated location details and previous genetic disease resources.SummaryDifference7%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Long-Term BMN 190 in CLN2 Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term BMN 190 in CLN2 Disease Clinical Trial page.